InsidersTradesSigma
Explore the complete record of transactions filed by Corning Luke, Director. Officer active across 1 company, notably Poseida Therapeutics, Inc.. Aggregated, 1 filings have been published. Activity tracked since 16 June 2022. The latest transaction was disclosed on 16 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Luke Corning is a Board Member at Poseida Therapeutics, Inc. He plays an important role in the governance of the company, contributing to strategic decision-making and overseeing research and development initiatives. His expertise in the biopharmaceutical field is crucial in guiding innovation.